Patients may start using a product or service while they are on the prescription, and then maintain use after theyve stopped, ideally slowing or preventing the weight gain that has been associated with the end of a GLP-1 prescription
Begin onboarding Stacking Guide Stacks Well With Do Not Combine With GLP-1 protocol guide Read the Semaglutide/B12 protocol guide Microdosing semaglutide or tirzepatide means running them below the FDA-approved starter dose
GLP-1 plays an integral role in blood sugar regulation
And what we saw on the other side is an increased consumption of the healthier foods, you know, fruits and vegetables, salads, and bowls
Medicare does not cover GLP-1 medications for weight loss under Part D, although the Medicare Bridge Program launched July 1, 2026 provides $50 per month for Wegovy pen, Wegovy pill, Zepbound KwikPen, and Foundayo for eligible Medicare beneficiaries with BMI 27 and above and an obesity-related comorbidity, running through December 31, 2027 (PeptideDeck)